Cargando…
Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)?
Functional status assessed by the WHO-FC scale derived from adults is a known prognostic factor for pulmonary hypertension. Data on the usefulness of the Panama-FC scale in assessing children with pulmonary hypertension are limited. The study was performed to compare functional status results (WHO-F...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695665/ https://www.ncbi.nlm.nih.gov/pubmed/32772124 http://dx.doi.org/10.1007/s00246-020-02434-8 |
_version_ | 1783615238938034176 |
---|---|
author | Migdał, Anna Żuk, Małgorzata Jagiełłowicz-Kowalska, Dorota Powichrowska, Zuzanna Brzezińska-Rajszys, Grażyna |
author_facet | Migdał, Anna Żuk, Małgorzata Jagiełłowicz-Kowalska, Dorota Powichrowska, Zuzanna Brzezińska-Rajszys, Grażyna |
author_sort | Migdał, Anna |
collection | PubMed |
description | Functional status assessed by the WHO-FC scale derived from adults is a known prognostic factor for pulmonary hypertension. Data on the usefulness of the Panama-FC scale in assessing children with pulmonary hypertension are limited. The study was performed to compare functional status results (WHO-FC and Panama-FC) and to assess the usefulness of these scales in various clinical situations. The reliability of the Panama-FC questionnaire method for facilitating patient evaluation was also examined. 26 functional status assessments (7 in disease progression/after treatment intensification) in both scales were analyzed in 19 patients with PAH confirmed in RHC. WHO-FC, Panama-FC scales, and questionnaire-based on Panama-FC were conducted independently by three different physicians. Results of assessments were compared with each other and with 6MWD, NTproBNP level, and echo parameters (TAPSE, RV/LV ratio). The Panama-FC scale results obtained using the medical interview method and questionnaire did not differ. Both WHO-FC and Panama-FC classes well-reflected disease advancement confirmed by non-invasive parameters (NTproBNP, 6MWD, TAPSE, RV/LV ratio). Differences between grading the class in both scales were observed: 5pts were classified to II (Panama-FC) vs I (WHO-FC), 2pts were in lower risk group in WHO-FC (II) vs Panama (IIIa). Worsening or improvement after treatment intensification in functional status in both scales was connected with the significant change of NTproBNP level. The 6-min walking distance did not change. TAPSE, RV/LV ratio changed significantly in 3pts with IPAH, accordingly to change in WHO-FC and Panama-FC. WHO-FC and Panama-FC well reflect the disease advancement. The questionnaire method simplified the use of the Panama-FC scale. The Panama-FC scale appears to be better for assessing functional status during long-term follow-up, while the WHO-FC scale was more useful in short-term treatment monitoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00246-020-02434-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7695665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-76956652020-12-09 Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? Migdał, Anna Żuk, Małgorzata Jagiełłowicz-Kowalska, Dorota Powichrowska, Zuzanna Brzezińska-Rajszys, Grażyna Pediatr Cardiol Original Article Functional status assessed by the WHO-FC scale derived from adults is a known prognostic factor for pulmonary hypertension. Data on the usefulness of the Panama-FC scale in assessing children with pulmonary hypertension are limited. The study was performed to compare functional status results (WHO-FC and Panama-FC) and to assess the usefulness of these scales in various clinical situations. The reliability of the Panama-FC questionnaire method for facilitating patient evaluation was also examined. 26 functional status assessments (7 in disease progression/after treatment intensification) in both scales were analyzed in 19 patients with PAH confirmed in RHC. WHO-FC, Panama-FC scales, and questionnaire-based on Panama-FC were conducted independently by three different physicians. Results of assessments were compared with each other and with 6MWD, NTproBNP level, and echo parameters (TAPSE, RV/LV ratio). The Panama-FC scale results obtained using the medical interview method and questionnaire did not differ. Both WHO-FC and Panama-FC classes well-reflected disease advancement confirmed by non-invasive parameters (NTproBNP, 6MWD, TAPSE, RV/LV ratio). Differences between grading the class in both scales were observed: 5pts were classified to II (Panama-FC) vs I (WHO-FC), 2pts were in lower risk group in WHO-FC (II) vs Panama (IIIa). Worsening or improvement after treatment intensification in functional status in both scales was connected with the significant change of NTproBNP level. The 6-min walking distance did not change. TAPSE, RV/LV ratio changed significantly in 3pts with IPAH, accordingly to change in WHO-FC and Panama-FC. WHO-FC and Panama-FC well reflect the disease advancement. The questionnaire method simplified the use of the Panama-FC scale. The Panama-FC scale appears to be better for assessing functional status during long-term follow-up, while the WHO-FC scale was more useful in short-term treatment monitoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00246-020-02434-8) contains supplementary material, which is available to authorized users. Springer US 2020-08-09 2020 /pmc/articles/PMC7695665/ /pubmed/32772124 http://dx.doi.org/10.1007/s00246-020-02434-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Migdał, Anna Żuk, Małgorzata Jagiełłowicz-Kowalska, Dorota Powichrowska, Zuzanna Brzezińska-Rajszys, Grażyna Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? |
title | Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? |
title_full | Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? |
title_fullStr | Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? |
title_full_unstemmed | Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? |
title_short | Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)? |
title_sort | which functional classification scale is optimal for children with pulmonary hypertension (pah)? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695665/ https://www.ncbi.nlm.nih.gov/pubmed/32772124 http://dx.doi.org/10.1007/s00246-020-02434-8 |
work_keys_str_mv | AT migdałanna whichfunctionalclassificationscaleisoptimalforchildrenwithpulmonaryhypertensionpah AT zukmałgorzata whichfunctionalclassificationscaleisoptimalforchildrenwithpulmonaryhypertensionpah AT jagiełłowiczkowalskadorota whichfunctionalclassificationscaleisoptimalforchildrenwithpulmonaryhypertensionpah AT powichrowskazuzanna whichfunctionalclassificationscaleisoptimalforchildrenwithpulmonaryhypertensionpah AT brzezinskarajszysgrazyna whichfunctionalclassificationscaleisoptimalforchildrenwithpulmonaryhypertensionpah |